|
BKD
Brookdale Senior Living Inc.
BKD · Q4 FY2023
|
Q4 FY2023 |
|
BKD Q4 FY2023 transcript
|
|
TLRY
Tilray Brands, Inc.
TLRY · Q2 FY2024
|
Q2 FY2024 |
|
TLRY Q2 FY2024 transcript
|
|
PENG
Penguin Solutions, Inc.
PENG · Q1 FY2024
|
Q1 FY2024 |
|
PENG Q1 FY2024 transcript
|
|
RICK
Rci Hospitality Holdings, Inc.
RICK · Q1 FY2024
|
Q1 FY2024 |
|
RICK Q1 FY2024 transcript
|
|
NEOG
Neogen Corp
NEOG · Q2 FY2024
|
Q2 FY2024 |
|
NEOG Q2 FY2024 transcript
|
|
ATRO
Astronics Corp
ATRO · Q4 FY2023
|
Q4 FY2023 |
|
ATRO Q4 FY2023 transcript
|
|
ATRC
AtriCure, Inc.
ATRC · Q4 FY2023
|
Q4 FY2023 |
|
ATRC Q4 FY2023 transcript
|
|
JAZZ
Jazz Pharmaceuticals plc
JAZZ · Q4 FY2023
|
Q4 FY2023 |
|
JAZZ Q4 FY2023 transcript
|
|
SRPT
Sarepta Therapeutics, Inc.
SRPT · Q4 FY2023
|
Q4 FY2023 |
|
SRPT Q4 FY2023 transcript
|
|
GERN
Geron Corp
GERN · Q4 FY2023
|
Q4 FY2023 |
|
GERN Q4 FY2023 transcript
|
|
ANIP
Ani Pharmaceuticals Inc
ANIP · Q4 FY2023
|
Q4 FY2023 |
|
ANIP Q4 FY2023 transcript
|
|
CLPT
ClearPoint Neuro, Inc.
CLPT · Q4 FY2023
|
Q4 FY2023 |
|
CLPT Q4 FY2023 transcript
|
|
CMC
COMMERCIAL METALS Co
CMC · Q1 FY2024
|
Q1 FY2024 |
|
CMC Q1 FY2024 transcript
|
|
BLFS
Biolife Solutions Inc
BLFS · Q4 FY2023
|
Q4 FY2023 |
|
BLFS Q4 FY2023 transcript
|
|
SGRY
Surgery Partners, Inc.
SGRY · Q4 FY2023
|
Q4 FY2023 |
|
SGRY Q4 FY2023 transcript
|
|
ATEC
Alphatec Holdings, Inc.
ATEC · Q4 FY2023
|
Q4 FY2023 |
|
ATEC Q4 FY2023 transcript
|
|
LAB
Standard Biotools Inc.
LAB · Q4 FY2023
|
Q4 FY2023 |
|
LAB Q4 FY2023 transcript
|
|
REGN
Regeneron Pharmaceuticals, Inc.
REGN · Q4 FY2023
|
Q4 FY2023 |
|
REGN Q4 FY2023 transcript
|
|
ALNY
Alnylam Pharmaceuticals, Inc.
ALNY · Q4 FY2023
|
Q4 FY2023 |
|
ALNY Q4 FY2023 transcript
|
|
EXEL
Exelixis, Inc.
EXEL · Q3 FY2024
|
Q3 FY2024 |
|
EXEL Q3 FY2024 transcript
|
|
HELE
Helen Of Troy Ltd
HELE · Q3 FY2024
|
Q3 FY2024 |
|
HELE Q3 FY2024 transcript
|
|
RIGL
Rigel Pharmaceuticals Inc
RIGL · Q4 FY2023
|
Q4 FY2023 |
|
RIGL Q4 FY2023 transcript
|
|
RARE
Ultragenyx Pharmaceutical Inc.
RARE · Q4 FY2023
|
Q4 FY2023 |
|
RARE Q4 FY2023 transcript
|
|
ADMA
Adma Biologics, Inc.
ADMA · Q4 FY2023
|
Q4 FY2023 |
|
ADMA Q4 FY2023 transcript
|